RESEARCH TRIANGLE PARK, N.C., Aug. 18 /PRNewswire/ -- Bayer CropScience is cooperating closely with the U.S. Department of Agriculture and U.S. Food and Drug Administration in connection with the biotechnology traces Bayer CropScience identified in samples of commercial rice in the United States. The USDA and FDA have confirmed that this rice poses no human health, food or feed safety or environmental concern.
These traces relate to a pre-commercial rice line, LLRICE601, developed by Bayer CropScience that produces a protein conferring herbicide tolerance. The protein is well known to regulators and has been confirmed safe for food and feed use in a number of crops by regulators in many countries, including the EU, Japan, Mexico, U.S. and Canada.
Bayer CropScience has provided testing methods which are now being certified by the USDA. We are furthermore supporting several commercial laboratories in setting up a testing method for industry use if requested.
Forward-Looking Statements
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Bayer CropScience
CONTACT: Greg Coffey, +1-919-549-2404, for Bayer CropScience
